Allosteric Modulation of M1 Muscarinic Acetylcholine Receptor Internalization and Subcellular Trafficking

被引:28
|
作者
Yeatman, Holly R. [1 ]
Lane, J. Robert [1 ]
Choy, Kwok Ho Christopher [1 ]
Lambert, Nevin A. [2 ]
Sexton, Patrick M. [1 ]
Christopoulos, Arthur [1 ]
Canals, Meritxell [1 ]
机构
[1] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Melbourne, Vic 3052, Australia
[2] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA
基金
英国医学研究理事会;
关键词
Allosteric Regulation; Arrestin; G Protein-coupled Receptor (GPCR); Receptor Endocytosis; Trafficking; GPCR Regulation; Allosteric Modulator; PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN; KINASE; PHOSPHORYLATION; ENDOCYTOSIS; LIGANDS; SEQUESTRATION; PHARMACOLOGY; SELECTIVITY; MECHANISMS;
D O I
10.1074/jbc.M113.536672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Allosteric modulators are an attractive approach to achieve receptor subtype-selective targeting of G protein-coupled receptors. Benzyl quinolone carboxylic acid (BQCA) is an unprecedented example of a highly selective positive allosteric modulator of the M-1 muscarinic acetylcholine receptor (mAChR). However, despite favorable pharmacological characteristics of BQCA in vitro and in vivo, there is limited evidence of the impact of allosteric modulation on receptor regulatory mechanisms such as -arrestin recruitment or receptor internalization and endocytic trafficking. In the present study we investigated the impact of BQCA on M-1 mAChR regulation. We show that BQCA potentiates agonist-induced -arrestin recruitment to M-1 mAChRs. Using a bioluminescence resonance energy transfer approach to monitor intracellular trafficking of M-1 mAChRs, we show that once internalized, M-1 mAChRs traffic to early endosomes, recycling endosomes and late endosomes. We also show that BQCA potentiates agonist-induced subcellular trafficking. M-1 mAChR internalization is both -arrestin and G protein-dependent, with the third intracellular loop playing an important role in the dynamics of -arrestin recruitment. As the global effect of receptor activation ultimately depends on the levels of receptor expression at the cell surface, these results illustrate the need to extend the characterization of novel allosteric modulators of G protein-coupled receptors to encapsulate the consequences of chronic exposure to this family of ligands.
引用
收藏
页码:15856 / 15866
页数:11
相关论文
共 50 条
  • [31] Phosphorylation of the M1 Muscarinic Acetylcholine Receptor Mediates Neuroprotection
    Scarpa, Miriam
    Bradley, Sophie
    Tobin, Andrew
    Finlayson, Lisa
    Molloy, Colin
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 403 - 404
  • [32] M1 muscarinic acetylcholine receptor in Alzheimer's disease
    Shangtong Jiang
    Yanfang Li
    Cuilin Zhang
    Yingjun Zhao
    Guojun Bu
    Huaxi Xu
    Yun-Wu Zhang
    [J]. Neuroscience Bulletin, 2014, 30 (02) : 295 - 307
  • [33] Flavonoids with M1 Muscarinic Acetylcholine Receptor Binding Activity
    Swaminathan, Meyyammai
    Chee, Chin Fei
    Chin, Sek Peng
    Buckle, Michael J. C.
    Abd Rahman, Noorsaadah
    Doughty, Stephen W.
    Chung, Lip Yong
    [J]. MOLECULES, 2014, 19 (07): : 8933 - 8948
  • [34] Effects of M1 and M4 muscarinic acetylcholine receptor positive allosteric modulators on sleep and cognition in rodents
    Gould, Robert W.
    Nedelcovych, Michael T.
    Grannan, Michael D.
    Bubser, Michael
    Wood, Michael R.
    Lindsley, Craig W.
    Xiang, Zixiu
    Wess, Jurgen
    Conn, P. Jeffrey
    Jones, Carrie K.
    [J]. FASEB JOURNAL, 2013, 27
  • [35] Differential Effects of Allosteric M1 Muscarinic Acetylcholine Receptor Agonists on Receptor Activation, Arrestin 3 Recruitment, and Receptor Downregulation
    Davis, Albert A.
    Heilman, Craig J.
    Brady, Ashley E.
    Miller, Nicole R.
    Fuerstenau-Sharp, Maya
    Hanson, Bonnie J.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    Lah, James J.
    Levey, Allan I.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2010, 1 (08): : 542 - 551
  • [36] G Protein Coupling and Signaling Pathway Activation by M1 Muscarinic Acetylcholine Receptor Orthosteric and Allosteric Agonists
    Thomas, Rachel L.
    Mistry, Rajendra
    Langmead, Christopher J.
    Wood, Martyn D.
    Challiss, R. A. John
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (02): : 365 - 374
  • [37] M1 muscarinic acetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease
    Decker, Michael
    Holzgrabe, Ulrike
    [J]. MEDCHEMCOMM, 2012, 3 (07) : 752 - 762
  • [38] Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M1
    Spearing, Paul K.
    Cho, Hyekyung P.
    Luscombe, Vincent B.
    Blobaum, Anna L.
    Boutaud, Olivier
    Engers, Darren W.
    Rodriguez, Alice L.
    Niswender, Colleen M.
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Bender, Aaron M.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 47
  • [39] Substituted Benzylspiroindolin-2-one Analogues as Positive Allosteric Modulators of the Muscarinic Acetylcholine Receptor M1
    Rotella, David P.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (09): : 822 - 822
  • [40] Allosteric muscarinic M1 receptor action of hybrids related to the M1 agonist xanomeline and to tacrine
    Jumpertz, S.
    Fang, L.
    Decker, M.
    Zhang, Y.
    Mohr, K.
    Traenkle, C.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 15 - 15